HIMS Hims Hers Health Inc
Company Analysis
Latest News
🔴 HIMS is trading 8% down today after announcing a $300 million convertible notes offering
HIMS is trading 7.82% down at $23.09 after announcing a $300 million convertible senior notes offering due 2032. • The company plans to use the proceeds to...
🔴 HIMS is trading 4.3% down today on $300 million convertible notes offering
HIMS is trading 4.3% down at $23.98 after announcing plans to issue $300 million of convertible senior notes due 2032. • Proceeds are intended to fund...
🔴 HIMS is trading 4.3% down today on plans for a $300 million convertible notes offering
HIMS is trading at $23.98 (4.3% down) in pre-market after the company announced its intention to offer $300 million in convertible senior notes due 2032. •...
🟢 HIMS is trading 4.2% up today on rebound from multi-day pullback
HIMS is trading at $25.25 (4.2% up) as shares bounce following a sharp multi-day pullback earlier this week. • Traders appear to be reassessing the recent...
🔴 HIMS is trading 6.6% down today on Q1 earnings miss and branded GLP-1 margin concerns
HIMS is trading at $23.39 (-6.55%), extending a sharp post-earnings decline following yesterday's -14.1% drop. The company reported Q1 revenue of $608.1M,...
🔴 HIMS is trading 13.18% down today on Q1 earnings miss and margin contraction
HIMS is trading at $25.30 (-13.18%) following a Q1 2026 earnings miss and a sharp swing to a quarterly loss. • Revenue reached $608.1M against the $616.84M...
🔴 HIMS is trading 16% down today after Q1 earnings miss and strategic shift to GLP-1 drugs
HIMS is trading at $24.38 (-16%) in pre-market following a Q1 2026 earnings miss and a strategic pivot toward lower-margin branded GLP-1 medications. • The...
🔴 HIMS is trading 10.1% down today after missing Q1 revenue estimates amid GLP-1 shift
HIMS is trading at $26.19 (-10.1%) in after-hours trading after the company missed Q1 2026 revenue estimates despite raising its full-year guidance. • Revenue...
Hims & Hers Missed Earnings Badly — Can a Guidance Raise and a Novo Nordisk Deal Rescue a Stock That Just Lost 6.8%?
Shares shifted sharply after Hims & Hers Health posted a first quarter that fell short on virtually every line that matters to Wall Street. Revenue came in at...
Hims & Hers first quarter 2026 revenue and EPS miss estimates amid a strategic shift to branded GLP-1s.
Hims & Hers reported first quarter 2026 revenue of $608.1 million, a 4% increase year-over-year, and a net loss per share of $0.40. Both figures fell short of...
🟢 HIMS is trading 5% up today ahead of Q1 earnings and weight-loss category updates
HIMS is trading at $29.73 (+5.18%) as investors position ahead of its Q1 2026 earnings report, scheduled for release after the market close on May 11. •...
🟢 HIMS is trading 4% up today ahead of Q1 earnings and weight-loss updates
HIMS is trading at $29.47 (+4.24%) ahead of its Q1 2026 earnings report and highly anticipated updates regarding its weight-loss category. • Analysts project...
🟢 HIMS is trading 5% up today ahead of Q1 earnings and weight-loss updates
HIMS is trading at $29.81 (+5%) in pre-market action, building on last week's 10% gain as investors anticipate the company's Q1 2026 earnings report scheduled...
Hims & Hers Health Inc Q1 2026 Earnings Preview: What Analysts Expect on May 11, 2026
Hims & Hers Health Inc is projected to report Q1 2026 revenue of $616.9 million and earnings per share of $0.04, as the stock currently trades around $28.27...
🟢 Hims & Hers is trading 11% up today rebounding from Amazon selloff ahead of Q1 earnings
HIMS is trading at $28.36 (+10.56%) as shares stage a sharp rebound from yesterday's selloff triggered by Amazon's entry into the telehealth weight-loss...
🟢 HIMS is trading 5.5% up today as it rebounds from Amazon-driven selloff ahead of Q1 earnings
HIMS is trading at $27.07 (+5.5%) as of May 8, 2026, rebounding sharply from a 4.6% decline in the prior session triggered by concerns over Amazon's entry into...
Hims Bounces 4% After Amazon-Fueled Selloff, but Can a Subscription Model Survive the Retail Giant's GLP-1 Blitz?
Shares of Hims & Hers Health snapped back $26.71, up 4.1%, on May 8 after tumbling 4.6% the prior session — a whipsaw that captures Wall Street's confusion...
🟢 HIMS is trading 4.1% up today as investors reassess Amazon Pharmacy competition
HIMS is trading at $26.71, up 4.1% as investors reassess the competitive impact of Amazon Pharmacy's GLP-1 expansion. • The stock is rebounding sharply from a...
Hims & Hers Shares Slide 5%, Pressured by Amazon’s GLP-1 Delivery Expansion
Shares of Hims & Hers Health (HIMS) dropped 5% on Thursday. This decline follows Amazon Pharmacy’s expansion of same-day delivery for GLP-1 weight-loss drugs...
🔴 HIMS is trading 5% down today as investors weigh AI Labs launch
HIMS is trading at $25.48 (-5.23%) following the launch of Labs AI as investors question whether the company's AI healthcare ambitions justify the recent...